Advertisement
IMNM 外汇新闻
Immunome And Morphimmune To Combine In All-stock Transaction
Biopharmaceutical company Immunome (IMNM) and private biotechnology company Morphimmune announced Thursday that they have entered into a definitive merger agreement to combine in an all-stock transaction.
RTTNews
|
688天前
